Agi did his PhD in Toronto, Canada with Johan Heersche and Jane Aubin, and a postdoc in Vienna with Erwin Wagner. His main interests are in the control of bone and cartilage lineage development in the embryo and postnatally in metabolic bone disease and skeletal neoplasia. Experimental approaches include pluripotent stem cell differentiation technology and transgenic/knockout mouse models of bone disease.